DTE

28.19

-0.74%↓

IBE

19.705

+0.72%↑

ORA

17.53

-0.82%↓

RWE

56.22

+0.21%↑

ELE

36.57

+0.33%↑

DTE

28.19

-0.74%↓

IBE

19.705

+0.72%↑

ORA

17.53

-0.82%↓

RWE

56.22

+0.21%↑

ELE

36.57

+0.33%↑

DTE

28.19

-0.74%↓

IBE

19.705

+0.72%↑

ORA

17.53

-0.82%↓

RWE

56.22

+0.21%↑

ELE

36.57

+0.33%↑

DTE

28.19

-0.74%↓

IBE

19.705

+0.72%↑

ORA

17.53

-0.82%↓

RWE

56.22

+0.21%↑

ELE

36.57

+0.33%↑

DTE

28.19

-0.74%↓

IBE

19.705

+0.72%↑

ORA

17.53

-0.82%↓

RWE

56.22

+0.21%↑

ELE

36.57

+0.33%↑

Inicio・Lista de Acciones・STRATEC Biomedical AG

STRATEC Biomedical AG

Abierto

17.2 2.63

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

16.42

Máximo

17.26

Métricas clave
By Trading Economics
Ingresos	2.6M -1.7M
Ventas	-22M 53M
P/B Media del Sector	14.63 30.765
BPA	-0.357
Rentabilidad por dividendo	3.39
Margen de beneficios	-3.206
Empleados	1,343
EBITDA	-6.7M 4.1M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+69.49% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	3.39% 3.24%
Próximas Ganancias	14 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-6.1M 208M
Apertura anterior	14.57
Cierre anterior	17.2

STRATEC Biomedical AG Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 jul 2025, 17:24 UTC

Charlas de Mercado

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

Comparación entre iguales

Cambio de precio

STRATEC Biomedical AG previsión

Precio Objetivo

By TipRanks

69.49% repunte

Estimación a 12 Meses

Media 28 EUR 69.49%

Máximo 37 EUR

Mínimo 21 EUR

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para STRATEC Biomedical AG Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

Comprar

Mantener

Vender

De acuerdo con 3 analistas que ofrecen calificaciones bursátiles a para STRATEC Biomedical AG Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de STRATEC Biomedical AG

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.